Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Identification of a pan-gamma-secretase inhibitor response signature for notch-driven cholangiocarcinoma.

O'Rourke CJ, Matter MS, Nepal C, Caetano-Oliveira R, Ton PT, Factor VM, Andersen JB.

Hepatology. 2019 Jun 18. doi: 10.1002/hep.30816. [Epub ahead of print]

PMID:
31211856
2.

Expert moi non plus.

Matter M.

Rev Med Suisse. 2019 May 22;15(652):1100. French. No abstract available.

PMID:
31116531
3.

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients.

Broggi MAS, Maillat L, Clement CC, Bordry N, Corthésy P, Auger A, Matter M, Hamelin R, Potin L, Demurtas D, Romano E, Harari A, Speiser DE, Santambrogio L, Swartz MA.

J Exp Med. 2019 May 6;216(5):1091-1107. doi: 10.1084/jem.20181618. Epub 2019 Apr 11.

PMID:
30975896
4.

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, Kotsiliti E, Leone V, Peiseler M, Surewaard BGJ, Rath D, Ali A, Wolf MJ, Drescher H, Healy ME, Dauch D, Kroy D, Krenkel O, Kohlhepp M, Engleitner T, Olkus A, Sijmonsma T, Volz J, Deppermann C, Stegner D, Helbling P, Nombela-Arrieta C, Rafiei A, Hinterleitner M, Rall M, Baku F, Borst O, Wilson CL, Leslie J, O'Connor T, Weston CJ, Adams DH, Sheriff L, Teijeiro A, Prinz M, Bogeska R, Anstee N, Bongers MN, Notohamiprodjo M, Geisler T, Withers DJ, Ware J, Mann DA, Augustin HG, Vegiopoulos A, Milsom MD, Rose AJ, Lalor PF, Llovet JM, Pinyol R, Tacke F, Rad R, Matter M, Djouder N, Kubes P, Knolle PA, Unger K, Zender L, Nieswandt B, Gawaz M, Weber A, Heikenwalder M.

Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.

PMID:
30936549
5.

Predictive value of omental thickness on ultrasonography for diagnosis of unexplained ascites, an Egyptian centre study.

Salman MA, Salman AA, Hamdy A, Abdel Samie RM, Ewid M, Abouregal TE, Seif El Nasr SM, Elkassar H, Abdallah A, Yousef M, Mohammed Ismail AA, Alsebaey A, Matter M.

Asian J Surg. 2019 Mar 22. pii: S1015-9584(19)30021-1. doi: 10.1016/j.asjsur.2019.03.004. [Epub ahead of print] Review.

6.

La souffrance des soignants.

Matter M, Gauthey M.

Rev Med Suisse. 2019 Mar 20;15(643):656. French. No abstract available.

PMID:
30892851
7.

La claque.

Matter M.

Rev Med Suisse. 2019 Mar 6;15(641):568. French. No abstract available.

PMID:
30860334
8.

In vitro culture, transformation and genetic fidelity of Milk Thistle.

Rady MR, Saker MM, Matter MA.

J Genet Eng Biotechnol. 2018 Dec;16(2):563-572. doi: 10.1016/j.jgeb.2018.02.007. Epub 2018 Feb 23. Review.

9.

[Renal, vascular and urological variations and abnormalities in living kidney donor candidates].

Costa A, Matter M, Pascual M, Doerfler A, Venetz JP.

Prog Urol. 2019 Mar;29(3):166-172. doi: 10.1016/j.purol.2018.12.001. Epub 2019 Jan 28. French.

PMID:
30704916
10.

Engineering the Bioactivity of Flame-Made Ceria and Ceria/Bioglass Hybrid Nanoparticles.

Matter MT, Furer LA, Starsich FHL, Fortunato G, Pratsinis SE, Herrmann IK.

ACS Appl Mater Interfaces. 2019 Jan 23;11(3):2830-2839. doi: 10.1021/acsami.8b18778. Epub 2019 Jan 10.

PMID:
30571079
11.

Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion.

Gouttenoire J, Pollán A, Abrami L, Oechslin N, Mauron J, Matter M, Oppliger J, Szkolnicka D, Dao Thi VL, van der Goot FG, Moradpour D.

PLoS Pathog. 2018 Dec 10;14(12):e1007471. doi: 10.1371/journal.ppat.1007471. eCollection 2018 Dec.

12.

Lanthanide-Doped Hafnia Nanoparticles for Multimodal Theranostics: Tailoring the Physicochemical Properties and Interactions with Biological Entities.

Gerken LRH, Keevend K, Zhang Y, Starsich FHL, Eberhardt C, Panzarasa G, Matter MT, Wichser A, Boss A, Neels A, Herrmann IK.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):437-448. doi: 10.1021/acsami.8b20334. Epub 2018 Dec 17.

PMID:
30516969
13.

Bioactive nanoparticle-based formulations increase survival area of perforator flaps in a rat model.

Lese I, Graf DA, Tsai C, Taddeo A, Matter MT, Constantinescu MA, Herrmann IK, Olariu R.

PLoS One. 2018 Nov 26;13(11):e0207802. doi: 10.1371/journal.pone.0207802. eCollection 2018.

14.

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver.

AlAsfoor S, Rohm TV, Bosch AJT, Dervos T, Calabrese D, Matter MS, Weber A, Cavelti-Weder C.

Sci Rep. 2018 Oct 17;8(1):15331. doi: 10.1038/s41598-018-32853-w.

15.

Communiquer et protéger.

Matter M.

Rev Med Suisse. 2018 Oct 10;14(622):1824. French. No abstract available.

PMID:
30307148
16.

Occurrence and prognosis of lymph node metastases in patients selected for isolated limb perfusion with soft tissue sarcoma.

Crettenand F, Martin D, Cherix S, Demartines N, Matter M.

J Cancer. 2018 Sep 7;9(18):3311-3315. doi: 10.7150/jca.25696. eCollection 2018.

17.

Alternatives to patient specific verification measurements in proton therapy: a comparative experimental study with intentional errors.

Matter M, Nenoff L, Meier G, Weber DC, Lomax AJ, Albertini F.

Phys Med Biol. 2018 Oct 17;63(20):205014. doi: 10.1088/1361-6560/aae2f4.

PMID:
30234498
18.

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma.

Bordry N, Broggi MAS, de Jonge K, Schaeuble K, Gannon PO, Foukas PG, Danenberg E, Romano E, Baumgaertner P, Fankhauser M, Wald N, Cagnon L, Abed-Maillard S, Maby-El Hajjami H, Murray T, Ioannidou K, Letovanec I, Yan P, Michielin O, Matter M, Swartz MA, Speiser DE.

Oncoimmunology. 2018 May 31;7(8):e1462878. doi: 10.1080/2162402X.2018.1462878. eCollection 2018.

19.

Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.

Paradiso V, Garofoli A, Tosti N, Lanzafame M, Perrina V, Quagliata L, Matter MS, Wieland S, Heim MH, Piscuoglio S, Ng CKY, Terracciano LM.

J Mol Diagn. 2018 Nov;20(6):836-848. doi: 10.1016/j.jmoldx.2018.07.003. Epub 2018 Aug 22.

PMID:
30142445
20.

Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.

Marciel MP, Khadka VS, Deng Y, Kilicaslan P, Pham A, Bertino P, Lee K, Chen S, Glibetic N, Hoffmann FW, Matter ML, Hoffmann PR.

Oncotarget. 2018 Jul 20;9(56):30937. doi: 10.18632/oncotarget.25857. eCollection 2018 Jul 20.

21.

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.

Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, Piscuoglio S, Wieland S, Ringnalda F, Schwank G, Terracciano LM, Ng CKY, Heim MH.

Cell Rep. 2018 Jul 31;24(5):1363-1376. doi: 10.1016/j.celrep.2018.07.001.

22.

L’interprofessionnalité : des synergies centrées sur le patient.

Matter M.

Rev Med Suisse. 2018 May 23;14(608):1112. French. No abstract available.

PMID:
29797864
23.

Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.

Marciel MP, Khadka VS, Deng Y, Kilicaslan P, Pham A, Bertino P, Lee K, Chen S, Glibetic N, Hoffmann FW, Matter ML, Hoffmann PR.

Oncotarget. 2018 Feb 3;9(17):13407-13422. doi: 10.18632/oncotarget.24388. eCollection 2018 Mar 2. Erratum in: Oncotarget. 2018 Jul 20;9(56):30937.

24.

The protein histidine phosphatase LHPP is a tumour suppressor.

Hindupur SK, Colombi M, Fuhs SR, Matter MS, Guri Y, Adam K, Cornu M, Piscuoglio S, Ng CKY, Betz C, Liko D, Quagliata L, Moes S, Jenoe P, Terracciano LM, Heim MH, Hunter T, Hall MN.

Nature. 2018 Mar 29;555(7698):678-682. doi: 10.1038/nature26140. Epub 2018 Mar 21.

25.

The radiological evaluation process of the potential live kidney donor assessment programme at al-Shifa Hospital: study and clinical audit.

Abukhalil M, Mehjez O, Aladdam M, Bottcher B, Skaik S, Matter M.

Lancet. 2018 Feb 21;391 Suppl 2:S31. doi: 10.1016/S0140-6736(18)30397-0. Epub 2018 Feb 21.

PMID:
29553430
26.

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.

Ng CKY, Di Costanzo GG, Tosti N, Paradiso V, Coto-Llerena M, Roscigno G, Perrina V, Quintavalle C, Boldanova T, Wieland S, Marino-Marsilia G, Lanzafame M, Quagliata L, Condorelli G, Matter MS, Tortora R, Heim MH, Terracciano LM, Piscuoglio S.

Ann Oncol. 2018 May 1;29(5):1286-1291. doi: 10.1093/annonc/mdy083.

PMID:
29509837
27.

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.

Kancherla V, Abdullazade S, Matter MS, Lanzafame M, Quagliata L, Roma G, Hoshida Y, Terracciano LM, Ng CKY, Piscuoglio S.

Front Genet. 2018 Feb 2;9:2. doi: 10.3389/fgene.2018.00002. eCollection 2018.

28.

The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors.

Läubli H, Koelzer VH, Matter MS, Herzig P, Dolder Schlienger B, Wiese MN, Lardinois D, Mertz KD, Zippelius A.

Oncoimmunology. 2017 Oct 26;7(2):e1386362. doi: 10.1080/2162402X.2017.1386362. eCollection 2018.

29.

RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases.

Shi GX, Yang WS, Jin L, Matter ML, Ramos JW.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E190-E199. doi: 10.1073/pnas.1708584115. Epub 2017 Dec 26.

30.

Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression.

Lucarelli P, Schilling M, Kreutz C, Vlasov A, Boehm ME, Iwamoto N, Steiert B, Lattermann S, Wäsch M, Stepath M, Matter MS, Heikenwälder M, Hoffmann K, Deharde D, Damm G, Seehofer D, Muciek M, Gretz N, Lehmann WD, Timmer J, Klingmüller U.

Cell Syst. 2018 Jan 24;6(1):75-89.e11. doi: 10.1016/j.cels.2017.11.010. Epub 2017 Dec 13.

31.

Unusual presentations of functional parathyroid cysts: a case series and review of the literature.

El-Housseini Y, Hübner M, Boubaker A, Bruegger J, Matter M, Bonny O.

J Med Case Rep. 2017 Nov 29;11(1):333. doi: 10.1186/s13256-017-1502-1. Review.

32.

In vivo analysis at the cellular level reveals similar steatosis induction in both hepatitis C virus genotype 1 and 3 infections.

Campana B, Calabrese D, Matter MS, Terracciano LM, Wieland SF, Heim MH.

J Viral Hepat. 2018 Mar;25(3):262-271. doi: 10.1111/jvh.12816. Epub 2017 Nov 20.

PMID:
29086446
33.

Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.

Quintavalle C, Hindupur SK, Quagliata L, Pallante P, Nigro C, Condorelli G, Andersen JB, Tagscherer KE, Roth W, Beguinot F, Heim MH, Ng CKY, Piscuoglio S, Matter MS.

Cell Death Dis. 2017 Oct 26;8(10):e3138. doi: 10.1038/cddis.2017.512.

34.

Patients en otage : le chaos programmé.

Matter M.

Rev Med Suisse. 2017 Oct 25;13(580):1864. French. No abstract available.

PMID:
29071841
35.

High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.

Quagliata L, Quintavalle C, Lanzafame M, Matter MS, Novello C, di Tommaso L, Pressiani T, Rimassa L, Tornillo L, Roncalli M, Cillo C, Pallante P, Piscuoglio S, Ng CK, Terracciano LM.

Lab Invest. 2018 Jan;98(1):95-105. doi: 10.1038/labinvest.2017.107. Epub 2017 Oct 16.

36.

When you hear hoof beats … consider zebras - A diagnostic challenge.

Bausch K, Bosl M, Matter M, Gabrielli S, Neumayr A.

Travel Med Infect Dis. 2017 Sep;19:73-74. doi: 10.1016/j.tmaid.2017.09.005. Epub 2017 Sep 25. No abstract available.

PMID:
28958823
37.

Les défaites politiques dans le domainede la santé semblent sans conséquence sur la carrière.

Matter M.

Rev Med Suisse. 2017 Sep 27;13(576):1672. French. No abstract available.

PMID:
28953344
38.

Early complications after living donor nephrectomy: analysis of the Swiss Organ Living Donor Health Registry.

Burkhalter F, Huynh-Do U, Hadaya K, Matter M, Müller T, Binet I, Nolte C, Steiger J.

Swiss Med Wkly. 2017 Aug 25;147:w14497. doi: 10.4414/smw.2017.14497. eCollection 2017.

39.

The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura.

Ellithy HN, Ahmed SH, Shahin GH, Matter MM, Talatt M.

Hematology. 2018 Apr;23(3):169-174. doi: 10.1080/10245332.2017.1371479. Epub 2017 Aug 31.

PMID:
28856973
40.

Inguinal Bladder Hernia With Acute Ureteral Obstruction 14 Years After Kidney Transplantation: A Case Report.

Ghielmini E, Julita L, Cerantola Y, Matter M, Zingg T.

Transplant Proc. 2017 Sep;49(7):1593-1595. doi: 10.1016/j.transproceed.2017.04.003.

PMID:
28838448
41.

M. Berset et le Tarmed : un ministre au pays des Schtroumpfs.

Matter M.

Rev Med Suisse. 2017 Apr 5;13(557):776. French. No abstract available.

PMID:
28722375
42.

MAS : un ralliement de raison.

Matter M.

Rev Med Suisse. 2017 Feb 22;13(551):488. French. No abstract available.

PMID:
28714656
43.

[Sarcoma centres : a necessary tool in the management of patients and for research.]

Cherix S, Vauclair F, Morattel B, Vautrin M, Matter M, Montemurro M, Digklia A, Letovanec I, Omoumi P, Saucy F, Gonzalez M, Durham AD, Bosisio F, Zyska Cherix AC, Rudiger HA.

Rev Med Suisse. 2016 Dec 14;12(543):2172-2176. French.

PMID:
28707833
44.

La 2e intervention tarifaire impose la déshumanisation de la médecine.

Matter M, Chatelain D.

Rev Med Suisse. 2017 Jul 12;13(569):1360. French. No abstract available.

PMID:
28699718
45.

Rationnement et gel du progrès médical : Non, M. Berset !

Matter M.

Rev Med Suisse. 2016 Sep 28;12(532):1640. French. No abstract available.

PMID:
28686372
46.

Initiative de l’AMG sur le secret médical : vers une majorité au Grand Conseil.

Matter M.

Rev Med Suisse. 2016 Aug 31;12(528):1448. French. No abstract available.

PMID:
28675290
47.

[Adrenal surgery : Multidisciplinarity is mandatory].

Matthey Gié ML, Nicod Lalonde M, Gonzalez Rodriguez E, Demartines N, Matter M.

Rev Med Suisse. 2017 Jun 14;13(567):1253-1257. French.

PMID:
28643981
48.

L’OFSP serait-il sous l’influence des assureurs ?

Matter M, Lironi A.

Rev Med Suisse. 2017 May 31;13(565):1176. French. No abstract available.

PMID:
28639767
49.

Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.

Gero D, Dib F, Matter M, Pascual M, Venetz JP, Demartines N, Melloul E.

World J Surg. 2017 Nov;41(11):2940-2948. doi: 10.1007/s00268-017-4071-y.

PMID:
28634839
50.

Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.

Yuan D, Huang S, Berger E, Liu L, Gross N, Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, Weber J, Öllinger R, Simonavicius N, Reisinger F, Hartmann D, Meyer R, Reich M, Seehawer M, Leone V, Höchst B, Wohlleber D, Jörs S, Prinz M, Spalding D, Protzer U, Luedde T, Terracciano L, Matter M, Longerich T, Knolle P, Ried T, Keitel V, Geisler F, Unger K, Cinnamon E, Pikarsky E, Hüser N, Davis RJ, Tschaharganeh DF, Rad R, Weber A, Zender L, Haller D, Heikenwalder M.

Cancer Cell. 2017 Jun 12;31(6):771-789.e6. doi: 10.1016/j.ccell.2017.05.006.

Supplemental Content

Loading ...
Support Center